180 related articles for article (PubMed ID: 10980055)
21. Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD).
Zimmermann T; Hoppe-Lotichius M; Tripkovic V; Barreiros AP; Wehler TC; Zimmermann A; Schattenberg JM; Heise M; Biesterfeld S; Galle PR; Otto G; Schuchmann M
Eur J Intern Med; 2010 Jun; 21(3):208-15. PubMed ID: 20493424
[TBL] [Abstract][Full Text] [Related]
22. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C is a risk factor for death after liver retransplantation.
Pelletier SJ; Schaubel DE; Punch JD; Wolfe RA; Port FK; Merion RM
Liver Transpl; 2005 Apr; 11(4):434-40. PubMed ID: 15776460
[TBL] [Abstract][Full Text] [Related]
24. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
[TBL] [Abstract][Full Text] [Related]
25. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
Newell KA; Alonso EM; Whitington PF; Bruce DS; Millis JM; Piper JB; Woodle ES; Kelly SM; Koeppen H; Hart J; Rubin CM; Thistlethwaite JR
Transplantation; 1996 Aug; 62(3):370-5. PubMed ID: 8779685
[TBL] [Abstract][Full Text] [Related]
26. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
27. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
28. Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
Kim RD; Fujikawa T; Mizuno S; Schwartz JJ; Sorensen JB; Hemming AW; Fujita S
Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):559-65. PubMed ID: 21555941
[TBL] [Abstract][Full Text] [Related]
29. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
30. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
[TBL] [Abstract][Full Text] [Related]
31. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
32. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
Shahinian VB; Muirhead N; Jevnikar AM; Leckie SH; Khakhar AK; Luke PP; Rizkalla KS; Hollomby DJ; House AA
Transplantation; 2003 Mar; 75(6):851-6. PubMed ID: 12660514
[TBL] [Abstract][Full Text] [Related]
34. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
Lawal A; Ghobrial R; Te H; Artinian L; Eastwood D; Schiano TD
Transplant Proc; 2007 Dec; 39(10):3261-5. PubMed ID: 18089367
[TBL] [Abstract][Full Text] [Related]
35. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
Manga Sahin G; Sahin S; Kantarci G; Ergin H
Transplant Proc; 2006 Mar; 38(2):499-501. PubMed ID: 16549159
[TBL] [Abstract][Full Text] [Related]
36. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
Tector AJ; Fridell JA; Mangus RS; Shah A; Milgrom M; Kwo P; Chalasani N; Yoo H; Rouch D; Liangpunsakul S; Herring S; Lumeng L
Liver Transpl; 2004 Mar; 10(3):404-7. PubMed ID: 15004768
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study.
Saliba F; Lakehal M; Pageaux GP; Roche B; Vanlemmens C; Duvoux C; Dumortier J; Salamé E; Calmus Y; Maugendre D;
Liver Transpl; 2007 Jan; 13(1):136-44. PubMed ID: 17192854
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
Neumann UP; Berg T; Bahra M; Puhl G; Guckelberger O; Langrehr JM; Neuhaus P
Transplantation; 2004 Jan; 77(2):226-31. PubMed ID: 14742986
[TBL] [Abstract][Full Text] [Related]
39. Posttransplant lymphoproliferative disorder.
Everly MJ; Bloom RD; Tsai DE; Trofe J
Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127
[TBL] [Abstract][Full Text] [Related]
40. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
Roque J; Rios G; Humeres R; Volpi C; Herrera JM; Schultz M; Rios H; Rius M; Salgado C; Hepp J
Transplant Proc; 2006 Apr; 38(3):930-1. PubMed ID: 16647513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
